Aneurysmal Subarachnoid Hemorrhage Market Size, Share | Forecast Report [2021-2031]Posted by pooja on August 25th, 2022  The aneurysmal subarachnoid hemorrhage market has been anticipated to reach US$ 456.31 million during the forecast period from 2020 to 2030. Furthermore, the aneurysmal subarachnoid hemorrhage market is likely to exhibit a CAGR of 3.6% in the years to come. Aneurysmal subarachnoid hemorrhage (aSAH) has been a life-threatening stroke type that is caused by bleeding in the brain. There are numerous factors in the aneurysmal subarachnoid hemorrhage market that are predicted to fuel growth avenues, for instance rising geriatric population. The global aneurysmal subarachnoid hemorrhage market is segmented on the basis of diagnostic test, therapy, and geography. By diagnostic test, CT scan and MRI are the components of this market. Lumber puncture is mandatory in cases where imaging shows indefinite results. Some of the leading companies in the global aneurysmal subarachnoid market are Arbor Pharmaceuticals, Edge Therapeutics Inc., and Actelion Ltd. Key institutions that contribute to the global aneurysmal subarachnoid hemorrhage market are Chinese University of Hong Kong, Utrecht University, University of Miami, University of Cambridge, and the University of Calgary among others. Get Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=31 About TMR Research Contact: Like it? Share it! More by this author |